Mycophenolate mofetil Completed Phase 4 Trials for Transplantation, Kidney Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00087581Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
NCT00113269Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
NCT00121810Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients
NCT00337493Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
NCT00758602A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.
NCT00817687A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation
NCT00885820Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection
NCT00912678Minimizing Immunosuppression in Old for Old Kidney Transplantation
NCT01033864A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients
NCT01842269Evaluate the Efficacy and Safety of My-ReptĀ® Tablet vs. My-ReptĀ® Capsule in Combination With Tacrolimus in Kidney Transplant Patients